Millennium Management’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Sell |
564,120
-4,301
| -0.8% | -$13K | ﹤0.01% | 2752 |
|
|
2025
Q1 | $2.42M | Buy |
568,421
+196,968
| +53% | +$839K | ﹤0.01% | 2472 |
|
|
2024
Q4 | $1.96M | Buy |
371,453
+357,051
| +2,479% | +$1.89M | ﹤0.01% | 2526 |
|
|
2024
Q3 | $26.4K | Buy |
+14,402
| New | +$26.4K | ﹤0.01% | 3975 |
|
|
2024
Q1 | – | Sell |
-11,506
| Closed | -$21.5K | – | 4540 |
|
|
2023
Q4 | $21.5K | Sell |
11,506
-6,541
| -36% | -$12.2K | ﹤0.01% | 3893 |
|
|
2023
Q3 | $30.1K | Sell |
18,047
-6,501
| -26% | -$10.9K | ﹤0.01% | 3927 |
|
|
2023
Q2 | $58.7K | Sell |
24,548
-1,773
| -7% | -$4.24K | ﹤0.01% | 3943 |
|
|
2023
Q1 | $82K | Sell |
26,321
-3,305
| -11% | -$10.3K | ﹤0.01% | 4109 |
|
|
2022
Q4 | $79K | Sell |
29,626
-20,581
| -41% | -$54.9K | ﹤0.01% | 4355 |
|
|
2022
Q3 | $149K | Sell |
50,207
-10,577
| -17% | -$31.4K | ﹤0.01% | 4568 |
|
|
2022
Q2 | $178K | Sell |
60,784
-11,566
| -16% | -$33.9K | ﹤0.01% | 4502 |
|
|
2022
Q1 | $370K | Sell |
72,350
-33,895
| -32% | -$173K | ﹤0.01% | 4273 |
|
|
2021
Q4 | $717K | Buy |
106,245
+1,327
| +1% | +$8.96K | ﹤0.01% | 3745 |
|
|
2021
Q3 | $726K | Sell |
104,918
-24,462
| -19% | -$169K | ﹤0.01% | 3897 |
|
|
2021
Q2 | $1.26M | Buy |
129,380
+69,246
| +115% | +$674K | ﹤0.01% | 3543 |
|
|
2021
Q1 | $947K | Buy |
60,134
+4,875
| +9% | +$76.8K | ﹤0.01% | 3297 |
|
|
2020
Q4 | $1.34M | Buy |
55,259
+17,331
| +46% | +$420K | ﹤0.01% | 2737 |
|
|
2020
Q3 | $638 | Buy |
37,928
+28,698
| +311% | +$483 | ﹤0.01% | 2739 |
|
|
2020
Q2 | $271K | Sell |
9,230
-33,189
| -78% | -$974K | ﹤0.01% | 3005 |
|
|
2020
Q1 | $1M | Buy |
+42,419
| New | +$1M | ﹤0.01% | 1980 |
|
|
2016
Q3 | – | Sell |
-386
| Closed | -$124K | – | 3273 |
|
|
2016
Q2 | $124K | Buy |
+386
| New | +$124K | ﹤0.01% | 2754 |
|